Umbilical cord blood transplantation for acute myeloid leukemia
- PMID: 19468274
- DOI: 10.1097/MOH.0b013e3283257a60
Umbilical cord blood transplantation for acute myeloid leukemia
Abstract
Purpose of review: To discuss the recent advances in the field of umbilical cord blood (UCB) transplant (UCBT) for the treatment of adult acute myeloid leukemia. This topic is particularly relevant given the increasing use of UCBT and the plethora of clinical and biological studies being done to further optimize UCBT.
Recent findings: We will focus on clinical outcomes, results of nonmyeloablative UCBT, graft-versus-leukemia effect and graft-versus-host disease, the effects of UCBT on the immune system, and the role of multiple UCBTs and ex-vivo expansion.
Summary: Ultimately, these findings and research will allow us to expand UCB to a larger number of patients. In addition, a better understanding of the biology of UCB and subsequent manipulation of UCB and the immune system will allow us to improve the graft-versus-leukemia effect, improve engraftment, and decrease infectious complications after transplant.
Comment in
-
Myeloid disease.Curr Opin Hematol. 2009 Mar;16(2):63. doi: 10.1097/MOH.0b013e3283279a76. Curr Opin Hematol. 2009. PMID: 19468265 No abstract available.
Similar articles
-
Umbilical cord blood transplantation in adult myeloid leukemia.Bone Marrow Transplant. 2008 Mar;41(5):465-72. doi: 10.1038/sj.bmt.1705994. Epub 2008 Feb 4. Bone Marrow Transplant. 2008. PMID: 18246116 Review.
-
Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche.Bone Marrow Transplant. 2007 Jan;39(1):11-23. doi: 10.1038/sj.bmt.1705538. Bone Marrow Transplant. 2007. PMID: 17164824 Review.
-
New insights into cord blood stem cell transplantation.Curr Opin Hematol. 2008 Jul;15(4):279-84. doi: 10.1097/MOH.0b013e328304ae2c. Curr Opin Hematol. 2008. PMID: 18536563 Review.
-
Role of interleukin-15 in umbilical cord blood transplantation.Int Rev Immunol. 2008;27(6):518-31. doi: 10.1080/08830180802317940. Int Rev Immunol. 2008. PMID: 19065354 Review.
-
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment.Bone Marrow Transplant. 2003 Jul;32(2):145-50. doi: 10.1038/sj.bmt.1704091. Bone Marrow Transplant. 2003. PMID: 12838278
Cited by
-
Promising new sources for pluripotent stem cells.Stem Cell Rev Rep. 2010 Mar;6(1):15-26. doi: 10.1007/s12015-009-9102-0. Stem Cell Rev Rep. 2010. PMID: 20091142 Review.
-
Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP.Biochem Res Int. 2012;2012:685267. doi: 10.1155/2012/685267. Epub 2012 Mar 4. Biochem Res Int. 2012. PMID: 22496978 Free PMC article.
-
Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.Stem Cell Res Ther. 2024 Jul 29;15(1):234. doi: 10.1186/s13287-024-03830-0. Stem Cell Res Ther. 2024. PMID: 39075614 Free PMC article. Review.
-
Umbilical cord transplantation: epilogue.Semin Hematol. 2010 Jan;47(1):97-103. doi: 10.1053/j.seminhematol.2009.10.002. Semin Hematol. 2010. PMID: 20109617 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
